\Pain Reduction: May lessen discomfort associated with injuries (Animal Study)
Recently, new UV filters have been developed to enable a more complete coverage of the full UV spectrum, such as bis-(diethylaminohydroxybenzoyl) benzoyl piperazine (BDBP) [45], phenylene bis-diphenyltriazine [46], or the UVA1 filter methoxypropylamino cyclohexenylidene ethoxyethylcyanoacetate (MCE) with a peak of absorption at 385 nm [47] shown to significantly improve photoprotection against UV-induced hyperpigmentation [48, 49]
What they found: No serious adverse events triggered by AOD-9604 The most frequent side effects: headache (~5 %), occasional fatigue, at the same frequency as placebo No changes in IGF-1 levels, glycemia, blood pressure, heart rate No signals of cardiovascular, hepatic or renal toxicity Safety profile comparable to placebo Why it matters: From a safety perspective, AOD-9604 is one of the safest peptides in the clinical registry
In recent years, compounding pharmacies have jumped into the market for blockbuster GLP-1 drugs
Proper dosing is needed to achieve optimal blood sugar control and minimize the risk of side effects
